Society to Improve Diagnosis in Medicine Welcomes New President and New Board Member

Share Article

The Society to Improve Diagnosis in Medicine (SIDM) today welcomed Robert Trowbridge, MD, as the new President of the organization and Tina Grande as a member of the Board of Directors. Dr. Trowbridge is taking over as President following the end of Dr. David Newman-Toker’s term.

The Society to Improve Diagnosis in Medicine (SIDM) today welcomed Robert Trowbridge, MD, as the new President of the organization and Tina Grande as a member of the Board of Directors. Dr. Trowbridge is taking over as President following the end of Dr. David Newman-Toker’s term. The change took place during the November 6th SIDM Board meeting.

Dr. Trowbridge is an Associate Professor of Medicine at Tufts University School of Medicine and Director of Undergraduate Medical Curriculum at Maine Medical Center in Portland, Maine and he has served on the SIDM Board of Directors since 2018. He is a clinician-educator with expertise in teaching clinical reasoning and avoidance of diagnostic error. He has won over 20 clinical teaching awards and remains clinically active as a hospitalist. His research has centered on ways of helping to identify diagnostic errors and provide feedback to clinicians in a manner that improves diagnostic reliability with over 30 peer-reviewed publications and 20 book chapters.

“Bob brings decades of practice experience to the Board and a commitment to diagnostic excellence. He has been at the forefront of the national movement to improve diagnosis by advancing diagnostic education, leading major efforts to transform the way we train the next generation of clinicians. Bob understands where the field needs to focus its efforts, and he will bring strong leadership skills to guide SIDM along the right path,” said David Newman-Toker, MD, PhD. “It is obviously bittersweet to step down from my leadership role as SIDM’s President, but I am looking forward to Bob’s tenure. He will help lead the organization through some of its most important transitions yet, and I can’t think of anyone I’d rather see at the helm.”

Dr. Newman-Toker will continue to serve on the Board as Immediate Past President.

SIDM also announced that Tina Olson Grande, MHS, Executive Vice President for Policy of the Healthcare Leadership Council (HLC) has joined the Board of Directors.

HLC is a coalition of chief executives of the nation’s leading healthcare companies and organizations. Ms. Grande oversees all policy-related matters pertaining to delivery systems, payment reform, health information technology, patient safety, and healthcare quality. She is Chair of the Confidentiality Coalition, the leading health privacy coalition bringing together all sectors of the healthcare industry to ensure that federal policymakers find the right balance between the protection of health information and the efficient and interoperable systems needed to provide high quality care. Ms. Grande is a frequent speaker on health issues and her work has been published on numerous occasions.

“SIDM has made great strides over the last few years in bringing the problem of diagnostic quality and safety to the halls of Congress and with federal agencies. Tina’s insights will help us continue to focus strategically on the broad healthcare landscape including policies that will drive improvements to the diagnostic process,” said Paul Epner, CEO and co-founder of SIDM.

In addition to Dr. Trowbridge, Ms. Grande, Dr. Newman-Toker and Mr. Epner the SIDM Board includes:

  • Jennifer Campisano, JD, SIDM Secretary, attorney and advocate.
  • Edward Hoffer, MD, SIDM Treasurer, Associate Professor of Medicine, part-time, at Harvard Medical School and Senior Scientist at the Massachusetts General Hospital (MGH).
  • Helen Burstin, Executive Vice President and Chief Executive Officer, Council of Medical Specialty Societies (CMSS).
  • Beth Daley Ullem, MBA, nationally recognized governance expert and advocate for safety and quality in health care.
  • Gurpreet Dhaliwal, MD, Professor of Medicine, University of California San Francisco.
  • Ann Gaffey, President, Healthcare Risk and Safety Strategies.
  • Tom S. Lee, PhD, MBA, healthcare entrepreneur.
  • Doug Salvador, MD, MPH, Senior Vice President, Chief Quality Officer, Baystate Health, Chief -Medical Officer, Baystate Medical Center, Associate Professor of Medicine, University of Massachusetts Medical School- Baystate.
  • Ron Wyatt, MD, MHA, Vice-President and Patient Safety Officer, MCIC Vermont

###

About the Society to Improve Diagnosis in Medicine (SIDM)
The Society to Improve Diagnosis in Medicine (SIDM) catalyzes and leads change to improve diagnosis and eliminate harm from diagnostic error. We work in partnership with patients, their families, the healthcare community and every interested stakeholder. SIDM is the only organization focused solely on the problem of diagnostic error and improving the accuracy and timeliness of diagnosis. In 2015, SIDM established the Coalition to Improve Diagnosis, to increase awareness and actions that improve diagnosis. Members of the Coalition represent hundreds of thousands of healthcare providers and patients—and the leading health organizations and government agencies involved in patient care. Together, we work to find solutions that enhance diagnostic safety and quality, reduce harm, and ultimately, ensure better health outcomes for patients. Visit http://www.improvediagnosis.org to learn more. Follow us on Twitter and Facebook.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Visit website